Development of an Antibody Dependent Enhancement(ADE) Assay to Support SARS-CoV2 Vaccine Development
We have developed antibody dependent enhancement (ADE) assay that is capable to evaluating capacity of antibodies to enhance secondary infection with SARS-CoV2 and provide valuable insights into the pathogenesis of this viral infection. This method can play a critical role in development of effective and safe vaccine. The assay is reliable, easy to execute, automation friendly and can be performed in a routine laboratory without the need for a BSL-3 laboratory.
Видео Development of an Antibody Dependent Enhancement(ADE) Assay to Support SARS-CoV2 Vaccine Development канала Celerion - Clinical Research
Видео Development of an Antibody Dependent Enhancement(ADE) Assay to Support SARS-CoV2 Vaccine Development канала Celerion - Clinical Research
Показать
Комментарии отсутствуют
Информация о видео
2 июля 2020 г. 14:04:32
00:15:54
Другие видео канала
Cytokine Storm with ADE - Antibody-dependent Enhancement of CoronavirusSARS-CoV-2 Variants | UK + South African + Brazil VariantsVitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)COVID-19 Vaccines: MODERNA | PFIZER/BIONTECH | ASTRAZENECACOVID and the ACE-2 surface proteinCOVID-19 Q&A #2 - Antibody-Dependent Enhancement, Cross-Immunity, Immunity Duration & MoreCOVID 19 Vaccine Deep Dive: Safety, Immunity, RNA Production, (Pfizer Vaccine / Moderna Vaccine)Fc gamma receptor activation during viral infections: a double-edged swordWhat Antibody Levels Are Necessary For COVID-19 Protection?Antibody Dependent Enhancement: What Is It? Does it Occur With COVID 19 Vaccines?Coronavirus Mutations and COVID 19 Vaccine Implications with Shane Crotty, PhD (SARS CoV 2 Variants)Do COVID-19 Vaccines Cause Antibody-dependent Enhancement (ADE)?Optimizing Renal and Hepatic Impairment Clinical Trial DesignsPeptide Drug Development Clinical Pharmacological ConsiderationsCoronavirus Update 120: Anticoagulants (Blood Thinners) Improve Hospital Outcomes (Full Dose)Peptide Drug Development: Clinical Pharmacological ConsiderationsSeasonal Coronavirus Specific Antibodies and The Severity of COVID-19Autoimmune Diseases, the Impact of COVID-19 and Vaccine DevelopmentANTIBODY DEPENDENT ENHANCEMENT and SARS-CoV-2 LECTURE 13COVID-19 | Coronavirus: Treatment, Prognosis, Precautions